Results of a hydroxyapatite-coated (Furlong) total hip replacement: a 13- to 15-year follow-up

We describe the survival of 134 consecutive JRI Furlong hydroxyapatite-coated uncemented total hip replacements. The mean follow-up was for 14.2 years (13 to 15).Patients were assessed clinically, using the Merle d'Aubigné and Postel score. Radiographs were evaluated using Gruen zones for the stem and DeLee and Charnley zones for the cup. Signs of subsidence, radiolucent lines, endosteal bone formation (spot welds) and pedestal formation were used to assess fixation and stability of the stem according to Engh's criteria. Cup angle, migration and radiolucency were used to assess loosening of the cup. The criteria for failure were revision, or impending revision because of pain or loosening. Survival analysis was performed using a life table and the Kaplan-Meier curve.The mean total Merle d'Aubigné and Postel score was 7.4 pre-operatively and 15.9 at follow-up. During the study period 22 patients died and six were lost to follow-up. None of the cups was revised. One stem was revised for a periprosthetic fracture following a fall but none was revised for loosening, giving a 99% survival at 13 years. Our findings suggest that the long-term results of these hydroxyapatite-coated prostheses are more than satisfactory.     

采用羟基磷灰石涂层股骨柄假体行全髋置换术的早期疗效

目的总结采用羟基磷灰石(HA)涂层股骨柄假体行全髋关节置换术的早期疗效。方法2000年2月～2003年10月,采用钛合金HA涂层股骨柄假体行无骨水泥全髋关节置换术65例(70髋)。术前诊断:股骨颈骨折30例,骨关节炎15例,股骨头缺血性坏死9例,人工股骨头术后松动8例,类风湿性髋关节炎2例,髋关节融合1例。分别于术后1周、3个月、6个月,以后每年一次行髋关节功能和X线片检查,其中44例接受双能X线骨密度仪(DEXA)的骨密度(BMD)检查。结果术后X线片提示股骨柄假体的初始固定均符合优良标准。随访2～5.5年,平均3年。髋关节功能从术前Harris平均评分32分(25～52分)恢复至最后随访时的平均96分(85～100分),至今无一髋表现股区痛或需行翻修手术。术后1年内的X线片测量显示:<1.5mm下沉者7髋,其余均无假体下沉。至今无一例显示股骨近端或髓内骨溶解,也无一例显示假体松动。DEXA检查显示BMD在术后下降,然后迅速恢复,3～6个月后可达到正常或接近正常水平,其中Ⅱ、Ⅵ区的BMD增加速度最快,有时甚至高于对照侧。按Engh标准评定,全部患者均获骨性固定。结论近段HA涂层能增强股骨柄假体的初始固定,促进早期骨长入和骨性生物学固定,阻止聚乙烯磨屑的髓内移行和骨溶解,故用于无骨水泥全髋置换术的早期疗效满意。     

Revision total hip replacement with a cemented long femoral component: minimum 9-year follow-up results

Background

Surgical revision after failed total hip replacement is a technically challenging procedure. The aim of this study was to analyze the long-term results of revision total hip replacement using a cemented long femoral component and identify factors that influence the results.

Methods

We retrospectively reviewed 34 hips in 33 patients who had undergone revision total hip replacement using a cemented long femoral component between 1994 and 2001. Hip function was evaluated according to the scoring system of the Japanese Orthopaedic Association. Radiographic examination was performed for evaluation of stem loosening, and its possible risk factors were investigated.

Results

The mean follow-up duration was 11.3 years (9–15). Perioperative complications included intraoperative femoral cortex perforation (six hips, 18 %), dislocation (five hips, 15 %), deep venous thrombosis (one hip, 3 %) and postoperative periprosthetic fracture (one hip, 3 %). The mean preoperative Japanese Orthopaedic Association hip score was 50.3 ± 14.9 vs 78.2 ± 11.5 at the latest follow-up. The Kaplan–Meier survival rate at 15 years, calculated using radiological failure or re-revision of the femoral component for any reason as the end point, was 87 or 100 %, respectively. The failure-free survival rate for the subgroup with a good-quality cement mantle was significantly higher than that for the subgroup with poor quality (p = 0.033).

Conclusions

The quality of cementation was identified as a significant risk factor for further loosening. Revision total hip replacement using a cemented long femoral component yielded satisfactory long-term results in this series.     

The results of a proximally-coated cementless femoral component in total hip replacement: a five- to 12-year follow-up

This study reviewed the results of a cementless anatomical femoral component to give immediate post-operative stability, and with a narrow distal section in order not to contact the femoral cortex in the diaphysis, ensuring exclusively metaphyseal loading. A total of 471 patients (601 hips) who had a total hip replacement between March 1995 and February 2002 were included in the study. There were 297 men and 174 women. The mean age at the time of operation was 52.7 years (28 to 63). Clinical and radiological evaluation were performed at each follow-up. Bone densitometry was carried out on all patients two weeks after operation and at the final follow-up examination. The mean follow-up was 8.8 years (5 to 12). The mean pre-operative Harris hip score was 41 points (16 to 54), which improved to a mean of 96 (68 to 100) at the final follow-up. No patient complained of thigh pain at any stage. No acetabular or femoral osteolysis was observed and no hip required revision for aseptic loosening of either component. Deep infection occurred in two hips (0.3%) which required revision. One hip (0.2%) required revision of the acetabular component for recurrent dislocation. Bone mineral densitometry revealed a minimal bone loss in the proximal femur. This cementless anatomical femoral component with metaphyseal loading but without distal fixation produced satisfactory fixation and encourages proximal femoral loading.     

羟基磷灰石涂层股骨柄假体全髋关节置换术的中期疗效

目的 评价羟基磷灰石涂层股骨柄假体伞髋关节置换术的中期疗效.方法 2000年2月至2001年2月,采用U2钛合金羟基磷灰石涂层股骨柄假体行非骨水泥全髋关节置换术65例(70髋),男20例,女45例;年龄40～82岁,平均63岁.术前诊断:股骨颈骨折30例,髋关节骨关节炎15例,股骨头缺血性坏死9例,人工股骨头术后松动8例,类风湿髋关节炎2例,髋关节融合术后1例.分别于术后1周、3个月、6个月随访,以后每年随访1次,对髋关节功能(Harris评分)和X线片进行复查.结果 4例死于癌症,余61例(66髋)获7～8年随访,平均7.5年.末次随访时髋关节Harris评分85～100分,平均96分.3髋(4.5%)出现轻度大腿痛,无一髋需行翻修术治疗.术后1年内假体下沉小于1.5 mm者7髋,此后未再出现假体下沉.术后3～6个月在Gruen 2区和6区近段羟基磷灰石涂层部位出现典型的骨锚固征及松质骨和皮质骨密度增高影像.此后所有患者包括年龄大于70岁和Dorr C型髓腔者均无柄端周围的骨质增生或"底座征",也尤股骨近段或远段髓内骨溶解及假体松动.按Engh标准评定全部患者均获骨性固定.结论 羟基磷灰石涂层能增强股骨柄假体的初始固定,促进早期骨长入和生物学固定,阻止聚乙烯磨屑的髓内迁移和远段髓内骨溶解,用于非骨水泥全髋置换术中期疗效满意.     

羟基磷灰石涂层股骨柄假体全髋关节置换术的中期疗效

目的 评价羟基磷灰石涂层股骨柄假体伞髋关节置换术的中期疗效.方法 2000年2月至2001年2月,采用U2钛合金羟基磷灰石涂层股骨柄假体行非骨水泥全髋关节置换术65例(70髋),男20例,女45例;年龄40～82岁,平均63岁.术前诊断:股骨颈骨折30例,髋关节骨关节炎15例,股骨头缺血性坏死9例,人工股骨头术后松动8例,类风湿髋关节炎2例,髋关节融合术后1例.分别于术后1周、3个月、6个月随访,以后每年随访1次,对髋关节功能(Harris评分)和X线片进行复查.结果 4例死于癌症,余61例(66髋)获7～8年随访,平均7.5年.末次随访时髋关节Harris评分85～100分,平均96分.3髋(4.5%)出现轻度大腿痛,无一髋需行翻修术治疗.术后1年内假体下沉小于1.5 mm者7髋,此后未再出现假体下沉.术后3～6个月在Gruen 2区和6区近段羟基磷灰石涂层部位出现典型的骨锚固征及松质骨和皮质骨密度增高影像.此后所有患者包括年龄大于70岁和Dorr C型髓腔者均无柄端周围的骨质增生或"底座征",也尤股骨近段或远段髓内骨溶解及假体松动.按Engh标准评定全部患者均获骨性固定.结论 羟基磷灰石涂层能增强股骨柄假体的初始固定,促进早期骨长入和生物学固定,阻止聚乙烯磨屑的髓内迁移和远段髓内骨溶解,用于非骨水泥全髋置换术中期疗效满意.     

Grit-blasted and hydroxyapatite-coated total hip arthroplasty: an 11- to 14-year follow-up study

We report long-term results of the first clinical trial of hydroxyapatite-coated total hip arthroplasty conducted in Japan. The hemispherical cup and the straight-tapered stem were made of titanium alloy with a grit-blasted, hydroxyapatite-coated surface. The surface roughness before and after hydroxyapatite coating was 1.4µm and 3.4µm, respectively. Thirty-three patients (35 hips) were followed prospectively; of these, 1 patient was lost to follow-up, 5 were deceased at the latest follow-up, and 27 were followed for 11 to 14 years. Two cups and one stem (two patients) were revised. Survivorship, with radiological acetabular loosening as the endpoint, was 62.3% at 14 years. At the latest radiological follow-up, stable fixation with bone ongrowth was achieved in 46% of the acetabular cups and 89% of the femoral stems. Acetabular cups with host bone coverage of less than 60% had a high rate of failure. The suboptimal result of the hydroxyapatite-coated smooth cup indicates that porous coatings under the hydroxyapatite coating would be beneficial for hydroxyapatite-coated total hip implants, especially for the acetabular components.     

Long-term outcome in an uncemented, hydroxyapatite-coated total knee replacement: a 15- to 18-year survivorship analysis

A consecutive series of patients with a hydroxyapatite-coated uncemented total knee replacement (TKR) performed by a single surgeon between 1992 and 1995 was analysed. All patients were invited for clinical review and radiological assessment. Revision for aseptic loosening was the primary outcome. Assessment was based on the Knee Society clinical score (KSS) and an independent radiological analysis. Of 471 TKRs performed in 356 patients, 432 TKRs in 325 patients were followed for a mean of 16.4 years (15 to 18). The 39?TKRs in 31 patients lost to follow-up had a mean KSS of 176 (148 to 198) at a mean of ten years. There were revisions in 26 TKRs (5.5%), of which 11 (2.3%) were for aseptic loosening. Other further surgery was carried out on 49 TKRs (10.4%) including patellar resurfacing in 20, arthrolysis in 19, manipulation under anaesthetic in nine and extensor mechanism reconstruction in one. Survivorship at up to 18 years without aseptic loosening was 96% (95% confidence interval 91.9 to 98.1), at which point the mean KSS was 176 (134 to 200). Of 110 knees that underwent radiological evaluation, osteolysis was observed in five (4.5%), one of which was revised. These data indicate that uncemented hydroxyapatite-coated TKR can achieve favourable long-term survivorship, at least as good as that of cemented designs.     

A randomized trial of hydroxyapatite-coated femoral stems in total hip arthroplasty: a 13-year follow-up

A prospective randomized trial comparing hydroxyapatite (HA)-coated and non-HA-coated femoral total hip arthroplasty components was conducted. Sixty-one consecutive patients undergoing primary hip arthroplasty were randomized to receive an identical femoral component with or without HA. Forty-eight hips were available for review at an average of 13 years and 5 months after surgery. The only femoral stem revised was secondary to femoral fracture after mitral valve area. All femoral stems were well fixed on x-ray with no evidence of loosening. There was no statistically significant difference in the revision rates or in the Harris hip score between the HA vs non-HA-coated groups. This study suggests there is no clinical advantage to the use of a hydroxyapatite coating on the femoral component of this design for primary total hip arthroplasty.     

Precoated femoral component in primary hybrid total hip arthroplasty: results at a mean 10-year follow-up

This is a mid-term report at 10 years' mean follow-up of a study of a precoated femoral component used in primary hybrid total hip arthroplasty (THA). Of an original cohort of 98 hips undergoing THA performed by one surgeon, 75 hips in 65 patients (mean age, 67 years) were prospectively followed up for 7 to 12 years (mean, 10 years). All hips had the same porous coated acetabular component and a precoated femoral component (with an oval cross-section) implanted using Simplex bone cement (Howmedica, Rutherford, NJ). There was no femoral component loosening or revision. Two acetabular components in patients with rheumatoid arthritis and protrusio acetabulae had radiographic loosening; however, only 1 was symptomatic and was revised. Acetabular osteolysis was seen in 4 hips (5.3%), and minor femoral osteolysis was seen in 3 hips (4%). Used in this manner in this patient population, precoating is not detrimental to successful fixation at 10 years' mean follow-up of primary hybrid THA.     

Mid-term results with primary uncemented total hip replacement: a 7- to 11-year follow-up

We reviewed 102 uncemented total hip replacements (THRs) in 90 patients with a mean age of 66 years (range, 33–87 years) and with an average postoperative follow-up period of 8.5 years (range, 7–11 years). The patients were prospectively observed clinically using the Harris hip score (HHS). The excellent and good results totaled over 90%. We had two serious complications treated by revisions, one for an “alarming” stem migration and a second one for an improper stem neck height. We had one late infection, and one early postoperative death. We had no mechanical loosenings or osteolysis. We found a common, up to 2 mm, slow migration of the cup and stem during the first 2 postoperative years. This was symptomless and was considered to be adaptive. Early, rapid, painful, severd, progressive, multidirectional migration is of concern. We used this uncemented prosthesis for patients of all ages. The rate of radiolucent, non-sclerotic demarcation was minimal (2%), limited, less than 2 mm wide and resolving. The occurrence of thigh pain was minimal (2%) and resolved. We believe that our results reflect the properties of this prosthesis and our surgical technique. Received: 14 January 2000/Accepted in revised form: 15 April 2000     

解剖型羟基磷灰石喷涂Ribbed股骨柄和臼杯全髋关节置换术患者的8年随访观察

目的探讨解剖柄羟基磷灰石(HA)涂层Ribbed髋假体行全髋关节置换(THA)术后的中期疗效。方法自1999年6月至2002年5月,采用解剖柄HA涂层Ribbed髋假体施行非骨水泥固定THA手术患者126例,获随访71例84髋,男29例,女42例;年龄39～76岁,平均58岁。术前诊断包括股骨头缺血坏死18例(双侧9例),股骨颈骨折23例,髋关节发育不良14例(双侧4例),髋关节骨关节炎16例。术后7～10d,6个月和每年1次随访X线拍片,对髋关节功能依末次随访状况行Harris评分。结果依末次随访时取Harris评价法,获85～100分39例(46髋),75～84分32例(38髋)。轻微大腿痛3例3髋(4.2%),X线片显示轻微骨吸收3例(3髋)(4.2%),无一患髋需行翻修术。术后1～2年内股骨柄下沉1.5～2mm者2例(3髋),下沉2～2.5mm者1例(1髋),此后再无发现明显下沉患者。术后6个月至3年X线显示于HA涂层部位近段骨吸收于Gruen5、6区2例(2髋)和3、5区1例(1髋),所有患者的骨锚固和松质骨、皮质骨骨密度轻度增高现象,显示髋假体-骨固定良好。结论解剖柄HA涂层Ribbed髋假体的初始固定能促进早期骨长入达到生物固定目标,并阻遏聚乙烯磨屑髓内迁徙致大腿痛和骨吸收,其中期疗效肯定。     

Long-term results of Alpina Postero-stabilized total knee replacement: 10- to 16-year follow-up

One hundred and ninety-four primary knee arthroplasties were done between 1992 and 1998 with Alpina Postero-Stabilized prosthesis. Eighty-eight knees were available for the long-term follow-up at a mean of 12?years. The mean IKS score improved from 103.1?±?21.9 points preoperatively to 161.5?±?25.6 at the latest follow-up (P?<?0.001). Eighty-four percent of the knees were rated good and excellent. The mean flexion significantly improved from 110° preoperatively to 117.5° at the latest follow-up (P?<?0.001). Two knees were revised: 1 due to infection and 1 due to femorotibial malalignment. Eight other knees were revised: 7 for isolated patella addition, 1 for patella replacement. Excluding patella failure, the 12-year Kaplan-Meier survivorship for the entire cohort was 98.8 (95% CI, 97.2–100%). Alpina Postero-Stabilized TKA showed good long-term results.     

Long-term follow-up of anatomic graduated component total knee arthroplasty: a 15- to 20-year survival analysis

The aims of this study were to determine survival rate, the clinical performance, and radiologic results of an Anatomic Graduated Component (AGC) total knee arthroplasty (TKA). Survival analysis was assessed by analyzing all hospital records of 211 AGC TKAs in 177 patients after 15 to 20 years. The survival rate was 87%, with failure defined as revision for any reason including infection. The main reasons for failure were infection and failure of the metal-backed patellar component. Clinical evaluation of 30 patients (33 TKAs) and questionnaires of 20 patients (23 TKAs) were taken, showing moderate to good results (mean Knee Society Score, 51; mean Western Ontario and McMaster Universities Osteoarthritis index, 82; mean University of California Los Angeles score, 4). Radiologic evaluation of 13 TKAs in 12 patients showed that none was suspect for loosening. Three knees showed significant medial wear but no clinical complaints. In conclusion, this is one of the first studies showing that AGC total knee prosthesis has good results 15 to 20 years after surgery.     

The stanmore total hip arthroplasty: A 15- to 20-year follow-up study

An ongoing study was made of 804 primary Stanmore total hip prostheses implanted in 839 patients between 1973 and 1991. The earliest surviving implants were brought back for radiologic and clinical review in 1995 at an average of 17 years after surgery. The remainder of the patients still living were sent a questionnaire to assess their current status. Survivorship was 95% at 10 years, 85% at 15 years, and 73% at 20 years. The average Merle d'Aubigné—Postel score was excellent up until 14 years. Patient satisfaction remained high until 22 years. Overall, 10% of the prostheses had failed. The results of this study suggest that the Stanmore prosthesis is capable of producing satisfactory long-term results that compare favorably with those of other cemented prostheses.     

Simultaneous bilateral total hip arthroplasty with hydroxyapatite-coated implants: a 20-year follow-up

Bilateral hip arthroplasty has been reported to be a safe and effective way to treat bilateral hip arthritis in a selective group of patients. We report a follow-up of 30 patients who underwent simultaneous bilateral total hip arthroplasty with hydroxyapatite implants and were followed for an average of 19.4 years. Patients had an average Harris Hip Score of 90 at the latest follow-up (range, 78-99). The average Western Ontario and McMaster Universities Arthritis Index questionnaire index score was 12 (range, 0-41), with high functional results on the 12-Item Short Form Health Survey (SF-12) and Oxford 12 questioners. Using the Kaplan-Meier survivorship analysis, with revision for any reason as an end point, survivorship was 94% at 12 years, 88% at 15 years, 74% at 18 years, and 61% at 23 years. All revisions were for the acetabular component, and the survivorship for the femoral component was 100% throughout the 23-year period. We conclude that bilateral uncemented total hip arthroplasty can provide satisfactory long-term clinical, radiological, and functional outcomes in patients even with older-generation polyethylene liners and stem designs.     

Clinical experience with a modular noncemented femoral component in revision total hip arthroplasty: 4- to 7-year results

A series of 163 revision total hip arthroplasties performed using a modular proximally porous-coated device was reviewed. Twenty patients died before achieving minimum follow-up, and 13 hips with Paprosky type IV femora were excluded. One patient was lost to follow-up. Minimum 4-year clinical data on the remaining 129 hips showed an improvement in modified Harris hip scores, from an average of 47.7 to 87.5. Spot welds at the sleeve-bone interface were found in 83 of the 102 hips with minimum radiographic follow-up. The aseptic failure rate was 2.9%; these hips showed progressive subsidence, with 1 resulting in the only repeat revision in the series. Three hips had osteolytic lesions of <5 mm; none threatened implant stability. There were no complications related to modularity.     

Results of a hydroxyapatite-coated modular femoral stem in primary total hip arthroplasty. A minimum 5-year follow-up

The use of a modular metaphyseal-diaphyseal femoral stem in primary total hip arthroplasty is infrequent. We analyze 94 ESOP (Fournitures Hospitalieres, Heimsbrunn, France) cementless 2-piece modular stems after a minimum 5 years of follow-up. There were 2 aseptic femoral stem loosenings and no cases with thigh pain. Mean femoral canal filling was 90%. Radiographic ingrowth was obtained in 83 (P < .001). At 7 years, the survival rate for femoral aseptic loosening was 97.8% and no stem was at risk for revision (95% confidence interval, 94.8%-100%). This prosthesis provides good clinical results with absence of pain and excellent radiographic results. It is an option in femora with good bone quality. Femoral osteopenia and cortical widening were infrequent, and the modular metaphyseal-diaphyseal junction was not a problem in vivo.     

Primary total hip replacement with a noncemented acetabular component: minimum 5-year clinical follow-up

The results of 123 total hip replacements with a noncemented Harris-Galante I acetabular component were reviewed (minimum 5-year clinical follow-up). The average clinical follow-up was 7 years (range, 5-10.8 years). No acetabular components were revised for loosening. One cup was revised for recurrent dislocation. In 3 cases, the acetabular liner was replaced at the time of femoral component revision (aseptic loosening), and in 1 case, a liner was revised because of recurrent dislocations. Of the hips, 92 had a complete set of radiographs for analysis. None of the acetabular components had migrated. Of the 92 acetabular components, 90 were considered radiographically stable (98%). Of these hips, 24 had linear radiolucencies of < or =2 mm in < or =2 of 4 zones and were considered stable. Two cups (2%) were considered possibly unstable. One of these had a linear radiolucent line in 3 zones, and the other had an osteolytic lesion measuring 6 x 11 mm in greatest dimensions. No acetabular components were definitely unstable. The average Harris Hip Score improved from 50 points (range, 17-89 points) preoperatively to 95 points (range, 74-99 points) at the latest follow-up examination. The average Hospital for Special Surgery hip score improved from 21 points (range, 10-31 points) preoperatively to 38 points (range, 27-40) at the last follow-up examination. Noncemented acetabular fixation with the Harris-Galante I component showed excellent clinical results at a minimum of 5 years' follow-up.     

Cementless total hip replacement using second-generation components: a 12- to 16-year follow-up

We reviewed 123 second-generation uncemented total hip replacements performed on 115 patients by a single surgeon between 1993 and 1994. The acetabular component used in all cases was a fully porous-coated threaded hemispheric titanium shell (T-Tap ST) with a calcium ion stearate-free, isostatically compression-moulded polyethylene liner. The titanium femoral component used was a Taperloc with a reduced distal stem. No patient was lost to follow-up. Complete clinical and radiological follow-up was obtained for all 123 hips at a mean of 14 years (12 to 16). One femoral component was revised after a fracture, and three acetabular components for aseptic loosening. No additional femoral or acetabular components were judged loose by radiological criteria. Mild proximal femoral osteolysis was identified in two hips and minor acetabular osteolysis was present in four. The mean rate of penetration of the femoral head was 0.036 mm/year (0.000 to 0.227). These findings suggest that refinements in component design may be associated with excellent long-term fixation in cementless primary total hip replacement.